Innovating for every women, every child

The report, 'Innovating for Every Woman, Every Child', published  by The Lancet, highlights business models that could harness new infrastructure to improve the health of women, children and infants in low-income countries. Examples include LifeSpring Hospitals in India, a chain of low-cost hospitals that provide healthcare to urban women who earn roughly US$3–$6 a day; text message printers that connect African laboratories to community clinics via mobile phone networks; D-Tree International in Zanzibar, which provides health workers with easy-to-use mobile phones that guide them through the screening, examination, counselling and treatment of patients; and a safe, affordable and long-lasting meningitis vaccine called MenAfriVac, designed specifically for Africa.

Sahajanand Laser Technology SUSHRUTA Innovation Award (SIA) 2012

The Sahajanand Laser Technology SUSHRUTA Innovation Award (SIA) is a nationwide competition in India  for the most innovative Medical Device Idea / Prototype. The competition is open for groups of students  pursuing degree (Bachelors / Master Level / Ph.D) under Biomedical Engineering, Medical Technology or related subjects from a recognized Indian University / Institution. The project / idea should be related to Medical Devices / Technology. 

The unique feature of the competition is that students need not come out with new ideas, they can build on the prior work done in the institute. 14 teams get 3 months time and grant of Rs 40,000/-  for each team to improve the existing and all invited to participate in an international exhibition on Medical Technology and Equipment.

Last date 15th October. Contact:  DL Pandya, dlpandya@gmail.com

Veol Labs-converting ideas to Medical equipment

Veol Labs is a contract product development company, focused exclusively on medical devices. The company was formed with a purpose of providing quality medical devices development servicesthat would (i) provide our clients with superior but cost effective medical device expertise & (ii) partner with our clients to improve the lives of the people who would be using their products.

The team comprises world class professionals who are specialists in the Contract Design, Development, Validation and Manufacture of Class II and Class III therapeutic, diagnostic and surgical devices.Mangesh Patankar, with years of experience at Johnson & Johnson started this venture.Products developed include Heart Monitor, Stress Urinary incontinence, Surgical Stapler.

PWC Medical Technology Innovation Scorecard

PwC’s Medical Technology Innovation Scorecard: The race for global leadership assesses nine countries’ capacity and capability for medical technology innovation: Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States. 

On a scale of 1 to 9, USA tops the list with score of 7.1, followed by Germany (5.4), UK(5.4), France (5.0), Japan (4.8), Israel (4.6), China (3.4) , Brazil (2.7) and India (2.7). India scores poorly on Innovative resources , Innovative output, Technology in market. India has 700 medical device companies as against 4,000 in China, India has 137 researchers per million of population while as China (only next to USA) has 1070 researchers per million.

We have a long way to catch up with China.

Sushruta Innovation Award (SIA)

As a part of Innovation Cluster initiative promoted by Dept of Science and Technology and implemented by Foundation for MSME Clusters , this student competition is planned for student innovators in Biomedical engg, Medical technology etc 

last date: 20th January 2011. Winning team gets cash prize of Rs 50,000/- and an opportunity to display the innovation at International Conference on Indian Medical devices , on 12th Feb 2011 at Ahmedabad. Details: 
http://www.innovationclusters.org/Pharmaceutical_Clusters_Initiative.html

simplified negative pressure wound therapy

Read this interesting innovation from MIT. It is facilitated by Centre for integration of medicine & innovative technology set with the mission improve patient care by facilitating collaboration among scientists, engineers and clinicians to catalyze the discovery, development and implementation of innovative technologies, emphasizing minimally invasive approaches.

Technology offer for Infant warmer

Villgro in partnership with Dr. Sathya Jeganathan (Neo Natal Specialist at Chengalpetu Medical College Hospital) has developed a Low Cost, Low Maintenance Infant Warmer targeted at the Rural Healthcare System

They are interested in transferring the Technology and related Know How to an Entrepreneur for commercialisation of the Infant Warmer.

Contact:

Rajeev Surana (Senior Associate – Technology Transfer)

Villgro (formerly Rural Innovation Network)

20/6, Lakshmipuram, 2nd Street, Lloyds Road,

Royapettah, CHENNAI 600014 (India)

t: 91-44-28112108 Ext.32

m: 91-9381755790

rajeev@rinovations.org

www.rinovations.org

International Conference on "Medical Electronics" and Exhibition

FICCI supported by DSIR(Department of Scientific and Industrial Research), Ministry of Science and Technology, is organizing the Second International Conference on "Medical Electronics" and Exhibition 2^nd time of its kind in Asia . at Federation House, New Delhi, on 19 & 20 February 2009, The Conference Theme : "Opportunity India the Innovators' Choice and World Destination" .

The Conference and Exhibition, which is held with Government and International Participation, offers opportunity to present Advancements, Breakthroughs and Showcase latest Product developments. Global Medical Electronics Fraternity, use this platform for Focused awareness, Opinion Building and Advantages, with Scientist, Doctors, policy makers, regulators, B2B and interdisciplinary stakeholders.

Select Speakers are Relevant Ministries, Regulators, Doctors, Scientists Academics from BARC, DIT, DSIR, AIIMS, Air Force Hospital , Zurich University Medical School, CEOs and top decision makers from Front line Global Companies in Medical Electronics, IT Telecomm /Software and Finance / Insurance & Banking Sector, Specialty Private Hospitals, Foreign R&D Organisations, and more.

The Conference includes an Exhibition of Technologies and Products at FICCI grounds for showcasing current trends and advancements. The Programme Details are:

Date & Time : 19 & 20 February , 2009, 9.30 AM - 6.30 P.M.

Venue : FICCI, Federation House,Tansen Marg,New Delhi 110001, India

Stanford-India Biodesign program

Stanford-India Biodesign program is aimed at training, mentoring and funding innovators in medical technology. Fellowship is for one year and second year is for developing technology invested in first year. Application dead line is May 8 2008.
Indian innovators can avail TePP grants for prototype development in 2nd year.
For details of program see: http://biodesign.stanford.edu/bdn/india/aboutbiodesign.jsp
For details of TePP see: www.dsir.gov.in

vision chip from X Cyton

Bangalore-based XCyton Diagnostics has launched the DNA macro chip, a molecular diagnostic kit, for identifying a range of pathogens causing eye diseases in the country recently. Promotor of this technology start-up, Dr. Ravi Kumar served as a scientist at AstraZeneca Research Foundation from 1986 to 1993 after which he went on to set up XCyton Diagnostics Limited.Scientists from the Centre for Cellular & Molecular Biology (CCMB) along with clinicians at the L V Prasad Eye Institute, both in Hyderabad; from Sankara Nethralaya, Chennai, and the RP Centre, New Delhi, have under the New Millennium Indian Technology Leadership Initiative (NMITLI) programme of the Council of Scientific and Industrial Research (CSIR), developed the DNA based diagnostic chip.

Translational Health Science and Technology Institute (THSTI)

MIT and the government of India’s Department of Biotechnology today launched a partnership that will result in the creation of a new Translational Health Science and Technology Institute (THSTI) in India.This new institute, which will be modeled after the Harvard-MIT Division of Health Sciences and Technology (HST), will include faculty from multiple disciplines and professions, offer degrees through multidisciplinary programs, and develop strong ties with other institutions. Funded by the Indian government, the Indian HST will be a multidisciplinary, multiprofessional research and training center that is highly interconnected with regional centers of excellence.
Contact:MIT News Office,Pamela Dumas Serfes, 617-253-2703,pdserfes@mit.edu
(source: Business wire)

Relisys Medical Devices

A firm promoted by Dr Krishan Reddy manufacturing Stents, Catheters etc crossed a major mile stone with receipt of FDA approval. This is the dream project of Dr. A.P.J. Abdul Kalam, H.E. The President of India who was responsible for inventing the first indigenous Coronary Stent "Kalam-Raju Stent", India's first indigenously developed stent in the year 1998. This first Coil stent was marketed by Relisys Medical Devices Ltd. This was the first indigenously developed Stent by DRDO and CARE Group.The product was withdrawn in 2001 as coil stents were phased out world wide. Advanced version of the company's Drug-Eluting Stent (DES) has been designed to eliminate the existing drawbacks of the currently available polymer coated Drug-Eluting Stent. Relisys' new DES consists of a Cobalt-Chromium Stent, coated with a porous carbon/carbon composite nano-structured matrix containing the active drug. The coating was developed and provided by Blue Membranes, the Germany based company in material and surface engineering. The coating eliminates the use of polymers thus completely reducing tissue inflammation and reaction.The animal trials for this version of advanced DES were recently completed at the Cardiovascular Research Institute, Washington D.C.Clinical trial were carried out at All India Institute of Medical Sciences, New Delhi, Cardio-Thoracic Centre, Military Hospital, Pune, and CARE Hospitals, Hyderabad.